A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f and Luveris Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique.
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Follitropin alfa (Primary) ; Lutropin alfa (Primary)
- Indications Infertility
- Focus Registrational; Therapeutic Use
- Sponsors Merck KGaA
- 12 May 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to discontinued.
- 12 Feb 2013 Planned End Date changed from 1 Aug 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 08 Jun 2012 Planned End Date changed from 1 Feb 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.